Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mao-Shin Lin

Showing results (111-120 of 120) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 120 results.
JACC. Cardiovascular Imaging|January 19, 2016
Predictors for Paravalvular Regurgitation After TAVR With the Self-Expanding Prosthesis: Quantitative Measurement of MDCT AnalysisSung-Han Yoon, Jung-Min Ahn, Yohei Ohno, et al.
Open Heart|January 9, 2021
Sex differences in patients undergoing transcatheter aortic valve replacement in AsiaPaul T L Chiam, Kentaro Hayashida, Yusuke Watanabe, et al.
JACC. Cardiovascular Interventions|May 7, 2016
Clinical Outcomes Following Transcatheter Aortic Valve Replacement in Asian PopulationSung-Han Yoon, Jung-Min Ahn, Kentaro Hayashida, et al.
BMJ Open|January 6, 2021
Rationale and design of the ADAPT-TAVR trial: a randomised comparison of edoxaban and dual antiplatelet therapy for prevention of leaflet thrombosis and cerebral embolisation after transcatheter aortic valve replacementHanbit Park, Do-Yoon Kang, Jung-Min Ahn, et al.
The American Journal of Cardiology|July 30, 2023
Effect of Edoxaban Versus Antiplatelet Therapy on Leaflet Thrombosis and Cerebral Thromboembolism After TAVI According to Major Clinical and Anatomic Factors in Prespecified Subgroup Analysis from the ADAPT-TAVR TrialJeen Hwa Lee, Jung-Min Ahn, Do-Yoon Kang, et al.
Heart (British Cardiac Society)|August 16, 2023
Impact of leaflet thrombosis on valve haemodynamic status after transcatheter aortic valve replacementMi Hee Jang, Jung-Min Ahn, Do-Yoon Kang, et al.
JACC. Cardiovascular Interventions|December 27, 2023
Frequency, Predictors, and Clinical Impact of Valvular and Perivalvular Thrombus After Transcatheter Aortic Valve ReplacementYeonwoo Choi, Jung-Min Ahn, Do-Yoon Kang, et al.
Circulation|April 4, 2022
Edoxaban Versus Dual Antiplatelet Therapy for Leaflet Thrombosis and Cerebral Thromboembolism After TAVR: The ADAPT-TAVR Randomized Clinical TrialDuk-Woo Park, Jung-Min Ahn, Do-Yoon Kang, et al.
American Heart Journal|December 20, 2023
Low- or standard-dose edoxaban versus antiplatelet therapy for leaflet thrombus and cerebral thromboembolism after TAVR: A prespecified analysis of randomized ADAPT-TAVR trialMijin Kim, Jung-Min Ahn, Do-Yoon Kang, et al.
JACC. Cardiovascular Interventions|March 1, 2023
Coronary Obstruction From TAVR in Native Aortic Stenosis: Development and Validation of Multivariate Prediction ModelJaffar M Khan, Norihiko Kamioka, John C Lisko, et al.
Pageof 12

Showing results (111-120 of 120) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 120 results.
JACC. Cardiovascular Imaging|January 19, 2016
Predictors for Paravalvular Regurgitation After TAVR With the Self-Expanding Prosthesis: Quantitative Measurement of MDCT AnalysisSung-Han Yoon, Jung-Min Ahn, Yohei Ohno, et al.
Open Heart|January 9, 2021
Sex differences in patients undergoing transcatheter aortic valve replacement in AsiaPaul T L Chiam, Kentaro Hayashida, Yusuke Watanabe, et al.
JACC. Cardiovascular Interventions|May 7, 2016
Clinical Outcomes Following Transcatheter Aortic Valve Replacement in Asian PopulationSung-Han Yoon, Jung-Min Ahn, Kentaro Hayashida, et al.
BMJ Open|January 6, 2021
Rationale and design of the ADAPT-TAVR trial: a randomised comparison of edoxaban and dual antiplatelet therapy for prevention of leaflet thrombosis and cerebral embolisation after transcatheter aortic valve replacementHanbit Park, Do-Yoon Kang, Jung-Min Ahn, et al.
The American Journal of Cardiology|July 30, 2023
Effect of Edoxaban Versus Antiplatelet Therapy on Leaflet Thrombosis and Cerebral Thromboembolism After TAVI According to Major Clinical and Anatomic Factors in Prespecified Subgroup Analysis from the ADAPT-TAVR TrialJeen Hwa Lee, Jung-Min Ahn, Do-Yoon Kang, et al.
Heart (British Cardiac Society)|August 16, 2023
Impact of leaflet thrombosis on valve haemodynamic status after transcatheter aortic valve replacementMi Hee Jang, Jung-Min Ahn, Do-Yoon Kang, et al.
JACC. Cardiovascular Interventions|December 27, 2023
Frequency, Predictors, and Clinical Impact of Valvular and Perivalvular Thrombus After Transcatheter Aortic Valve ReplacementYeonwoo Choi, Jung-Min Ahn, Do-Yoon Kang, et al.
Circulation|April 4, 2022
Edoxaban Versus Dual Antiplatelet Therapy for Leaflet Thrombosis and Cerebral Thromboembolism After TAVR: The ADAPT-TAVR Randomized Clinical TrialDuk-Woo Park, Jung-Min Ahn, Do-Yoon Kang, et al.
American Heart Journal|December 20, 2023
Low- or standard-dose edoxaban versus antiplatelet therapy for leaflet thrombus and cerebral thromboembolism after TAVR: A prespecified analysis of randomized ADAPT-TAVR trialMijin Kim, Jung-Min Ahn, Do-Yoon Kang, et al.
JACC. Cardiovascular Interventions|March 1, 2023
Coronary Obstruction From TAVR in Native Aortic Stenosis: Development and Validation of Multivariate Prediction ModelJaffar M Khan, Norihiko Kamioka, John C Lisko, et al.
Pageof 12